Analyst Research

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Natus Medical Inc gives Q3 2014 outlook in line with analysts' estimates; raises FY 2014 outlook


Wednesday, 23 Jul 2014 07:30am EDT 

Natus Medical Inc:Expects Q3 2014 revenue to be in the range of $86 -$89 mln.Expects Q3 2014 non-GAAP earnings per share to be in the range of $0.28 to $0.32.Expects FY 2014 revenue was increased to $347.5 -$352.5 mln compared to previous guidance of $345.0 -$350.0 mln.Expects FY 2014 non-GAAP earnings per share of $1.20 to $1.23, an increase from previous guidance of $1.18 to $1.21.Q3 2014 revenue of $87 mln, EPS of $0.31 - Thomson Reuters I/B/E/S.FY 2014 revenue of $349.5 mln, EPS of $ 1.20 - Thomson Reuters I/B/E/S. 

Company Quote

32.99
-1.09 -3.20%
5 Feb 2016